Date: 2026-03-31 Market cap: ~96B|Shareprice: 380 | Shares: ~253M FY ends: January 31 | Most recent quarter: Q4 FY26 (Jan-2026)
CrowdStrike is the premier pure-play cybersecurity platform — first to $5B ARR, dominant market share, genuine data moat, and a commercial model (Falcon Flex) that is transforming how customers buy security. The leading indicators are about as good as I've seen from a $96B company: net new ARR +47% YoY, pipeline +49%, Falcon Flex ARR +120%. These numbers are telling us revenue will re-accelerate, probably to 25%+ in FY27.
But the numbers have to match the theory, and the revenue line hasn't crossed 25% yet. The market is pricing the recovery as a certainty. At 20x TTM revenue and ~16x forward, this is a quality premium on a company that is still GAAP unprofitable at the operating level and running SBC at 23.6% of revenue. The commission amortization extension ($85-95M tailwind to non-GAAP FY27) adds a cosmetic layer that makes the margin story less clean than it appears. The DOJ/SEC investigation is unresolved and touches ARR methodology — low probability, but the tail risk is real.
I wouldn't sell it, and I wouldn't make it my largest position either. The setup is for a solid mid-teens compounder from here, not a 3-bagger. Good company, fair price — which means you're paying for quality, not getting it at a discount.
Conviction: 3.5/5. Hold or moderate position (5-8%). Add on a pullback to ~$330 (17x TTM) or on FY27 revenue crossing 25% YoY.
I could be wrong.
| Criterion | Threshold | Actual | Status |
|---|---|---|---|
| Revenue YoY growth | >30% preferred | 23.3% | CONDITIONAL — below threshold, but leading indicators (NNA +47%) confirm re-acceleration in progress |
| Gross margin | >70% | 75.8% GAAP / 79% Non-GAAP | PASS |
| Revenue per quarter | >$50M | $1,305M | PASS |
| Data availability | 4+ quarters | 19 quarters in DB | PASS |
| Recurring revenue | Yes | 95.2% subscription | PASS |
| Share dilution | Manageable | ~2.4% YoY | PASS |
Gate: Conditional pass. Revenue growth doesn't meet my 30% filter, but the 23.7pp gap between NNA growth (+47%) and revenue growth (+23.3%) is the widest in the company's history. Revenue is the lagging indicator here. I'll give it the benefit of the doubt — the leading indicators have to convert, and the theory is they will.
| Q1_FY25 | Q2_FY25 | Q3_FY25 | Q4_FY25 | Q1_FY26 | Q2_FY26 | Q3_FY26 | Q4_FY26 | |
|---|---|---|---|---|---|---|---|---|
| Apr-24 | Jul-24 | Oct-24 | Jan-25 | Apr-25 | Jul-25 | Oct-25 | Jan-26 | |
| Revenue ($M) | 921 | 964 | 1,010 | 1,059 | 1,103 | 1,169 | 1,234 | 1,305 |
| YoY % | 33.0% | 31.8% | 28.5% | 25.2% | 19.8% | 21.3% | 22.2% | 23.3% |
| QoQ % | 17.2% | 4.7% | 4.8% | 4.8% | 9.2% | 5.9% | 5.6% | 5.8% |
| QoQ $ Add | +$76M | +$43M | +$46M | +$48M | +$45M | +$66M | +$65M | +$71M |
| Gross Margin (GAAP) | 75.6% | 75.4% | 74.7% | 74.3% | 73.8% | 73.5% | 75.1% | 75.8% |
| Gross Margin (NG) | ~77% | 78% | ~78% | 78% | 78% | 78% | 78% | 79% |
| Op Margin (GAAP) | 0.7% | 1.4% | -5.5% | -7.5% | -11.3% | -9.7% | -5.6% | -0.5% |
| Op Margin (NG) | 23.2% | 25.0% | 19.9% | 21.2% | 18.2% | 21.8% | 21.4% | 25.0% |
| FCF ($M) | 323 | 272 | — | 240 | 298 | 284 | 296 | 376 |
| FCF Margin | 36.2% | — | — | — | 27.0% | 24.3% | 24.0% | 28.8% |
| SBC ($M) | 183 | 201 | 209 | 273 | 254 | 287 | 293 | 302 |
| EPS (GAAP) | $0.17 | $0.19 | -$0.07 | -$0.35 | -$0.44 | -$0.31 | -$0.14 | $0.15 |
| EPS (NG) | — | $0.95 | — | $0.81 | — | — | $0.96 | $1.12 |
| Q4_FY25 | Q1_FY26 | Q2_FY26 | Q3_FY26 | Q4_FY26 | |
|---|---|---|---|---|---|
| Ending ARR ($M) | 4,240 | 4,440 | 4,660 | 4,920 | 5,250 |
| ARR YoY % | — | 22% | 20% | 23% | 24% |
| Net New ARR ($M) | 224 | 194 | 221 | 265 | 331 |
| NNA YoY % | — | — | — | +73% | +47% |
| Falcon Flex ARR ($M) | — | — | — | 1,350 | 1,690 |
| Module 6+ % | — | — | 48% | 49% | 50% |
| Module 7+ % | — | — | 33% | 34% | 34% |
| Module 8+ % | — | — | 23% | 24% | 24% |
| NRR | — | — | — | — | 115% |
| GRR | — | — | — | — | 97% |
| Q4_FY25 | Q3_FY26 | Q4_FY26 | |
|---|---|---|---|
| Current DR ($M) | 2,733 | 2,852 | 3,421 |
| Non-Current DR ($M) | — | 1,212 | 1,332 |
| Total DR ($M) | ~3,729 | 4,063 | 4,753 |
| DR / TTM Revenue | — | ~87% | ~99% |
Revenue: Re-accelerating. Four consecutive quarters of YoY improvement: 19.8% → 21.3% → 22.2% → 23.3%. The QoQ dollar adds tell the story even more clearly: $45M → $66M → $65M → $71M across FY26, with Q4 the highest in the company's history. The trough was Q1 FY26 (the worst of the post-outage CCP drag). The direction is unmistakable.
Net new ARR: Explosive. Q4 NNA of $331M (+47% YoY) is an all-time record. Full-year NNA crossed $1B for the first time. This is the strongest leading indicator divergence from revenue in CRWD's history. NNA is currently running 24pp ahead of revenue growth. That gap must close — and it closes upward (revenue catches up to NNA, not the other way around).
Falcon Flex: Transformational. 1.69BendingARRfromFlexaccounts(+1201M ending ARR. The Reflex cycle (380 accounts, 7-month cycle, 26% average ARR lift; multi-Reflex at 48% lift) is a genuine land-and-expand flywheel that didn't exist two years ago. The example of one customer going from 1 module to 25 modules and $86M total contract value is illustrative of where this goes at scale.
Platform adoption: Deepening. Cloud/Identity/SIEM combined at $1.9B ending ARR (+45% YoY). NextGen SIEM at $585M+ (+75%). Identity at $520M+ (+34%). Cloud at $800M+ (+35%). These are three separate businesses, each at scale, each growing 35-75%. The single-agent architecture is a genuine structural advantage for module adoption.
Margins: Non-GAAP improving, GAAP still underwater. Non-GAAP gross margin hit a record 79%. Non-GAAP op margin at 25% in Q4. But GAAP op margin was -0.5% in the best quarter and -6.1% for the full year. The gap is SBC ($1,136M in FY26, or 23.6% of revenue). This is the elephant in the room.
| Metric | Value | Assessment |
|---|---|---|
| Market Cap | ~$96B | Large-cap |
| EV (market cap - cash + debt) | ~$91.5B | |
| TTM Revenue | $4,812M | |
| P/S (TTM) | 20.0x | Premium |
| P/S (NTM, FY27 guide mid) | 16.3x | |
| EV/S (TTM) | 19.0x | |
| EV/S (NTM) | 15.5x | |
| EV/GP (TTM GAAP) | 25.5x | GP = ~$3,589M |
| P/FCF (TTM) | 77x | FCF = $1,240M |
| Forward PE (NG, FY27) | 78x | NG EPS ~$4.84 |
| Revenue-PEG (P/S / YoY%) | 0.86x (TTM growth) | Reasonable by this heuristic |
| Rule of 40 (Q4) | 52.3 | 23.3% growth + 29.0% FCF margin |
Relative context:
If revenue is growing 23% and the P/S is 20, the PEG is 0.87x — that's roughly in the zone where you're paying a fair price for the growth you're getting. Compare to: NET at ~17x (growing ~28%), PANW at ~13x (growing ~14%), S1 at ~15x (growing ~30%). CRWD's premium is partially justified by scale ($5B ARR), retention (97% GRR), and platform breadth — but it's not cheap.
Market cap sanity check: At ~96B, CrowdStrikewouldneedtoreach 200B+ in 5 years for a 15%+ annual return (the minimum I'd accept for the risk). That requires roughly 12B + revenueat17xP/S.FY27guidedat 5.9B. Reaching $12B by FY31 requires ~20% CAGR from FY27 — achievable but not guaranteed. The math works if growth sustains above 20%. It doesn't work if growth settles into the mid-teens.
The valuation heuristic: For a company growing 23% with 79% gross margins, 25% non-GAAP op margins, and 29% FCF margins, 20x TTM revenue is fair. Not cheap, not egregious. The Rule of 40 at 52 supports a premium. But "fair" from a $96B base means the easy money has been made. The outage recovery re-rating from $300 to $380 already happened. Future returns depend on execution, not multiple expansion.
Leading indicators are as strong as I've ever seen at this scale. NNA +47%, pipeline +49%, Flex ARR +120% — all dramatically above the 23% revenue line. This is the clearest bullish divergence in the company's history.
Falcon Flex is a genuine commercial model innovation. Converting the post-outage CCP program into a land-and-expand mechanism (Reflex cycle) was operational jujitsu. 380 Reflex accounts at 26% average ARR lift in 7 months. This is the compounding engine.
Platform breadth creates multi-vector growth. Three separate billion-dollar businesses within the platform (endpoint/cloud, identity, SIEM) each growing 35-75%. Single-agent architecture makes this frictionless for customers. Module adoption is still only 50% at 6+ — the depth runway remains long.
Deferred revenue of $4.75B provides extraordinary visibility. That's ~99% of TTM revenue already contracted. This is not a company guessing at where next quarter comes from.
97% gross retention at $5B+ ARR is best-in-class. The outage didn't break the customer relationship. The MITRE ATT&CK 100% detection/100% protection score and 6th consecutive Gartner Customers' Choice validate the product.
FCF generation is real and growing. $1.24B FY26 FCF (26% margin), $376M in Q4 alone (29%). Record operating cash flow of $498M in Q4. The cash machine works.
Microsoft Azure marketplace partnership opens a massive new channel. Customers using Azure consumption commitments for Falcon is a frictionless adoption vector that didn't exist before.
AI security as structural tailwind. 1,800+ AI applications detected on endpoints, ~160M instances. AIDR growing 5x QoQ. This isn't theoretical — the demand is present today.
SBC at 23.6% of revenue is the biggest quality issue. FY26 SBC was $1,136M on $4,812M revenue. The GAAP/non-GAAP gap at the operating level is 1, 343M(1.05B NG profit vs. -293MGAAPloss).IlookatFCFasthecleanersignal, andFCFisgenuinelystrong(1.24B), but the SBC trajectory is going the wrong direction. In FY25 it was ~22%. It's rising, not falling. Management's target of ~20% SBC/revenue has not been met. Until this compresses, the "path to GAAP profitability" narrative is aspirational.
Commission amortization change is cosmetic margin improvement. Extending sales commission amortization from 4 years to 5 years adds 85 − 95MtoFY27non − GAAPoperatingincome.That′s6 − 71,442M midpoint). Management offset it with $74-80M in acquisition integration expenses — conveniently netting to a small number. But the gross change is meaningful. If I restate FY27 NG op income excluding the amortization benefit, the "margin expansion" story gets thinner. FCF doesn't have this distortion — always weight FCF over non-GAAP when accounting assumptions shift.
Revenue hasn't actually crossed 25% yet. The market is pricing 25-28% re-acceleration. FY27 guidance is 22-23%. Leading indicators say beat, but guidance itself is measured. If Q1 FY27 comes in at 23-24% (guide is ~23.3%), the "when does it actually inflect past 25%?" question persists. The bull case requires patience — I need to see it in the actual revenue line, not just in NNA.
DOJ/SEC investigation is unresolved and methodologically significant. This is not just about a $32M IRS deal. Investigators are examining "other government transactions." The investigation touches ARR reporting methodology — the same metric the entire bull case is built on. Disclosure Insight has flagged restatement risk. Probability of severe outcome is low, but the tail risk (restatement + federal debarment + trust destruction) is binary and devastating. No timeline for resolution.
Valuation limits upside from $96B. At 20x TTM, CrowdStrike is fairly priced for 23% growth. But "fair" means the return profile is a function of execution, not re-rating. If growth sustains at 22-25%, you compound at roughly that rate minus the premium you're paying today. If growth disappoints (sub-20%), the de-rating is swift — this is priced for recovery, not for stagnation.
SentinelOne closing the AI gap. Oppenheimer Feb 2026 channel checks rated Purple AI as superior to Charlotte AI for autonomous SOC use cases. CRWD leads on platform breadth and data scale, but AI-specific execution matters for the next leg of growth. Monitor this.
GAAP profitability in Q4 was fragile. The 38.7MGAAPnetincomewasproppedbyinterestincome( 40M+ per quarter on 5.2Bcash).StripinterestincomeandGAAPoperatinglosswas−6.9M. GAAP operating profitability has not been achieved on a sustained basis.
I haven't written about CRWD specifically before this analysis, but applying my framework:
What I expected entering this analysis:
What the data shows:
Updated assessment: The leading indicators upgraded my view. Net new ARR +47% and pipeline +49% are not numbers you see from a company growing into middle age. This is re-acceleration, and it's real. But I'm calibrating against valuation: at $96B, the market already sees what I see. The question isn't "is CRWD a good company?" — it obviously is. The question is "is there enough upside from here to justify the position size vs. alternatives?" And that's where I land at moderate conviction, not high.
Atlas scored CRWD at 3/5 conviction in their Q3 FY26 review, noting the FY27 initial guidance as the decisive catalyst. That catalyst has now resolved:
Atlas was right that the leading indicators would be strong. But I note that FY27 NNA guidance (+20-25%) is actually below FY26's actual +25%. Management isn't guiding for continued NNA acceleration — they're guiding for moderation. This is either conservative sandbagging (consistent with their guidance tightening pattern) or a signal that the recovery's peak growth rate has been reached. The 49% pipeline growth suggests sandbagging, but I'll let the data confirm.
I bump conviction to 3.5/5 vs. Atlas's 3/5, recognizing that Q4 results were strong and leading indicators upgraded, but the FY27 guide didn't fully validate the bull case.
Moderate conviction: 5-8% allocation.
"Don't let enthusiasm get ahead of conviction." The leading indicators are exciting. But they've been exciting at $380/share. I want to see them at $330 or see revenue actually print 25%+ before I go bigger.
CrowdStrike is the best-positioned pure-play cybersecurity platform in the world. The data moat, the Flex commercial model, the multi-vector platform growth, and the AI security tailwind are all real. The post-outage recovery is confirmed at the leading indicator level and playing out in the revenue line.
But the market knows this. At $96B, you're paying a fair price for a great company. SBC at 23.6% of revenue is a quality issue that won't resolve quickly. The DOJ/SEC investigation is an unresolved tail risk. GAAP profitability is fragile and interest-income-dependent. The commission amortization change muddies the margin story.
Moderate position. Hold. Add on weakness or on revenue confirmation above 25%. The numbers are pointing the right direction, but from this price, you need the numbers to actually show up — and I don't invest based on hope.
Bear